225 related articles for article (PubMed ID: 19515066)
1. Simvastatin inhibits angiotensin II-induced cardiac cell hypertrophy: role of Homer 1a.
Guo WG; Su FF; Yuan LJ; Yang GD; Shi XQ; Li RY; Shu Q; Liu XT; Lu ZF; Zheng QS
Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):40-5. PubMed ID: 19515066
[TBL] [Abstract][Full Text] [Related]
2. Negative feedback regulation of Homer 1a on norepinephrine-dependent cardiac hypertrophy.
Chiarello C; Bortoloso E; Carpi A; Furlan S; Volpe P
Exp Cell Res; 2013 Jul; 319(12):1804-1814. PubMed ID: 23664835
[TBL] [Abstract][Full Text] [Related]
3. Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes.
Li H; Shi S; Sun YH; Zhao YJ; Li QF; Li HZ; Wang R; Xu CQ
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):312-8. PubMed ID: 18986329
[TBL] [Abstract][Full Text] [Related]
4. [Stimulation of adenosine A1 receptor attenuates angiotensin II induced myocardial hypertrophy in neonatal rats via the extracellular signal-regulated kinase signal pathways].
Li ZY; Yang YH; Xing L
Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Aug; 41(8):698-703. PubMed ID: 24225244
[TBL] [Abstract][Full Text] [Related]
5. Crucial Role of ROCK2-Mediated Phosphorylation and Upregulation of FHOD3 in the Pathogenesis of Angiotensin II-Induced Cardiac Hypertrophy.
Zhou Q; Wei SS; Wang H; Wang Q; Li W; Li G; Hou JW; Chen XM; Chen J; Xu WP; Li YG; Wang YP
Hypertension; 2017 Jun; 69(6):1070-1083. PubMed ID: 28438902
[TBL] [Abstract][Full Text] [Related]
6. EndophilinA2 protects against angiotensin II-induced cardiac hypertrophy by inhibiting angiotensin II type 1 receptor trafficking in neonatal rat cardiomyocytes.
Liu Y; Shen HJ; Wang XQ; Liu HQ; Zheng LY; Luo JD
J Cell Biochem; 2018 Nov; 119(10):8290-8303. PubMed ID: 29923351
[TBL] [Abstract][Full Text] [Related]
7. [Extract of Ginkgo biloba and quercetin inhibit angiotensin-II induced hypertrophy in cultured neonatal rat cardiomyocytes].
Wu Y; Gu YM
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 May; 34(5):454-7. PubMed ID: 16776966
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II reduces cardiac AdipoR1 expression through AT1 receptor/ROS/ERK1/2/c-Myc pathway.
Li L; Zhang ZG; Lei H; Wang C; Wu LP; Wang JY; Fu FY; Zhu WG; Wu LL
PLoS One; 2013; 8(1):e49915. PubMed ID: 23349663
[TBL] [Abstract][Full Text] [Related]
9. Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy.
Hingtgen SD; Tian X; Yang J; Dunlay SM; Peek AS; Wu Y; Sharma RV; Engelhardt JF; Davisson RL
Physiol Genomics; 2006 Aug; 26(3):180-91. PubMed ID: 16670255
[TBL] [Abstract][Full Text] [Related]
10. Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro.
Aoki H; Richmond M; Izumo S; Sadoshima J
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):275-84. PubMed ID: 10727428
[TBL] [Abstract][Full Text] [Related]
11. Rosuvastatin inhibits norepinephrine-induced cardiac hypertrophy via suppression of Gh.
Choi EY; Chang W; Lim S; Song BW; Cha MJ; Kim HJ; Choi E; Jang Y; Chung N; Hwang KC
Eur J Pharmacol; 2010 Feb; 627(1-3):56-62. PubMed ID: 19883640
[TBL] [Abstract][Full Text] [Related]
12. The role of mAKAPβ in the process of cardiomyocyte hypertrophy induced by angiotensin II.
Guo H; Liu B; Hou L; The E; Li G; Wang D; Jie Q; Che W; Wei Y
Int J Mol Med; 2015 May; 35(5):1159-68. PubMed ID: 25739102
[TBL] [Abstract][Full Text] [Related]
13. sRAGE attenuates angiotensin II-induced cardiomyocyte hypertrophy by inhibiting RAGE-NFκB-NLRP3 activation.
Lim S; Lee ME; Jeong J; Lee J; Cho S; Seo M; Park S
Inflamm Res; 2018 Aug; 67(8):691-701. PubMed ID: 29796842
[TBL] [Abstract][Full Text] [Related]
14. Role of calcineurin in angiotensin II-induced cardiac myocyte hypertrophy of rats.
Fu M; Zhang J; Xu S; Pang Y; Liu N; Tang C
Chin Med Sci J; 2001 Mar; 16(1):1-4. PubMed ID: 12899339
[TBL] [Abstract][Full Text] [Related]
15. Tanshinone-induced ERs suppresses IGFII activation to alleviate Ang II-mediated cardiac hypertrophy.
Chen YF; Lee NH; Pai PY; Chung LC; Shen CY; Rajendran P; Chen YF; Chen RJ; Padma Viswanadha V; Kuo WW; Huang CY
J Recept Signal Transduct Res; 2017 Oct; 37(5):493-499. PubMed ID: 28812967
[TBL] [Abstract][Full Text] [Related]
16. Celecoxib, but not rofecoxib or naproxen, attenuates cardiac hypertrophy and fibrosis induced in vitro by angiotensin and aldosterone.
Wang BH; Bertucci MC; Ma JY; Adrahtas A; Cheung RY; Krum H
Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):912-8. PubMed ID: 20497423
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II induced upregulation of G alpha q/11, phospholipase C beta 3 and extracellular signal-regulated kinase 1/2 via angiotensin II type 1 receptor.
Bai H; Wu LL; Xing DQ; Liu J; Zhao YL
Chin Med J (Engl); 2004 Jan; 117(1):88-93. PubMed ID: 14733781
[TBL] [Abstract][Full Text] [Related]
18. High density lipoprotein downregulates angiotensin II type 1 receptor and inhibits angiotensin II-induced cardiac hypertrophy.
Lin L; Gong H; Ge J; Jiang G; Zhou N; Li L; Ye Y; Zhang G; Ge J; Zou Y
Biochem Biophys Res Commun; 2011 Jan; 404(1):28-33. PubMed ID: 21094634
[TBL] [Abstract][Full Text] [Related]
19. Activation of peroxisome proliferator-activated receptor-γ downregulates soluble epoxide hydrolase in cardiomyocytes.
Pang W; Li N; Ai D; Niu XL; Guan YF; Zhu Y
Clin Exp Pharmacol Physiol; 2011 Jun; 38(6):358-64. PubMed ID: 21291492
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin Upregulates MiR-133a in Cardiac Hypertrophy through AMPK Activation and Reduced ERK1/2 Phosphorylation.
Li Y; Cai X; Guan Y; Wang L; Wang S; Li Y; Fu Y; Gao X; Su G
PLoS One; 2016; 11(2):e0148482. PubMed ID: 26845040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
